Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

AMNEAL PHARMACEUTICALS, INC Operating Expenses 2010-2025 | AMRX

AMNEAL PHARMACEUTICALS, INC operating expenses from 2010 to 2025. Operating expenses can be defined as the sum of all operating expenses for the given industry.
  
AMNEAL PHARMACEUTICALS, INC Annual Operating Expenses
(Millions of US $)
2024 $2,545
2023 $2,189
2022 $2,307
2021 $1,941
2020 $1,901
2019 $1,875
2018 $1,683
2017 $789
2016 $733
2015 $791
2014 $507
2013 $518
2012 $499
2011 $413
2010 $486
2009 $288
AMNEAL PHARMACEUTICALS, INC Quarterly Operating Expenses
(Millions of US $)
2025-03-31 $595
2024-12-31 $655
2024-09-30 $614
2024-06-30 $606
2024-03-31 $670
2023-12-31 $603
2023-09-30 $544
2023-06-30 $519
2023-03-31 $523
2022-12-31 $574
2022-09-30 $501
2022-06-30 $758
2022-03-31 $474
2021-12-31 $526
2021-09-30 $500
2021-06-30 $468
2021-03-31 $447
2020-12-31 $490
2020-09-30 $517
2020-06-30 $454
2020-03-31 $441
2019-12-31 $420
2019-09-30 $491
2019-06-30 $424
2019-03-31 $540
2018-12-31 $474
2018-09-30 $402
2018-06-30 $595
2018-03-31 $212
2017-12-31 $161
2017-09-30 $176
2017-06-30 $215
2017-03-31 $236
2016-12-31 $-123
2016-09-30 $501
2016-06-30 $168
2016-03-31 $188
2015-12-31 $251
2015-09-30 $194
2015-06-30 $196
2015-03-31 $150
2014-12-31 $130
2014-09-30 $132
2014-06-30 $134
2014-03-31 $110
2013-12-31 $117
2013-09-30 $133
2013-06-30 $124
2013-03-31 $144
2012-12-31 $136
2012-09-30 $116
2012-06-30 $136
2012-03-31 $110
2011-12-31 $123
2011-09-30 $94
2011-06-30 $108
2011-03-31 $88
2010-12-31 $89
2010-09-30 $181
2010-06-30 $104
2010-03-31 $112
2009-12-31 $124
2009-09-30 $55
2009-06-30 $54
2009-03-31 $55
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $2.351B $2.794B
Amneal Pharmaceuticals LLC is an integrated specialty pharmaceutical company. It focused on developing, manufacturing and distributing generic, brand and biosimilar products. The company operates primarily in North America, Asia and Europe. Amneal Pharmaceuticals LLC, formerly known as Impax Laboratories Inc., is based in New Jersey, United States.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $87.021B 32.64
Zoetis (ZTS) United States $72.987B 27.23
Daiichi Sankyo, - (DSNKY) Japan $49.540B 25.20
Takeda Pharmaceutical (TAK) Japan $45.278B 9.01
Sandoz Group AG (SDZNY) Switzerland $20.747B 0.00
Summit Therapeutics (SMMT) United States $17.831B 0.00
Merck (MKKGY) Germany $16.820B 12.32
United Therapeutics (UTHR) United States $13.772B 12.18
Shionogi (SGIOY) Japan $13.084B 13.11
Neurocrine Biosciences (NBIX) United States $12.155B 41.63
IPSEN (IPSEY) France $9.731B 0.00
Orion OYJ (ORINY) Finland $8.979B 24.28
Corcept Therapeutics (CORT) United States $7.934B 64.50
Stevanato Group S.p.A (STVN) Italy $7.504B 45.89
Madrigal Pharmaceuticals (MDGL) United States $6.455B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.976B 0.00
Grifols, S.A (GRFS) Spain $5.500B 0.00
Ionis Pharmaceuticals (IONS) United States $5.416B 0.00
Ono Pharmaceutical (OPHLF) Japan $5.040B 15.33
Soleno Therapeutics (SLNO) United States $3.809B 0.00
Catalyst Pharmaceuticals (CPRX) United States $3.004B 10.53
Crinetics Pharmaceuticals (CRNX) United States $2.898B 0.00
Hypermarcas (HYPMY) Brazil $2.755B 18.12
BioCryst Pharmaceuticals (BCRX) United States $2.170B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $2.090B 0.00
Recursion Pharmaceuticals (RXRX) United States $1.833B 0.00
Guardian Pharmacy Services (GRDN) United States $1.678B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $1.638B 0.00
Indivior (INDV) United States $1.610B 6.83
Evotec AG (EVO) Germany $1.410B 0.00
ARS Pharmaceuticals (SPRY) United States $1.401B 0.00
Dyne Therapeutics (DYN) United States $1.325B 0.00
Ocular Therapeutix (OCUL) United States $1.196B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.090B 21.81
Harrow (HROW) United States $1.038B 0.00
Ardelyx (ARDX) United States $0.971B 0.00
Collegium Pharmaceutical (COLL) United States $0.958B 5.17
Avadel Pharmaceuticals (AVDL) Ireland $0.905B 0.00
Enliven Therapeutics (ELVN) United States $0.827B 0.00
Cronos Group (CRON) Canada $0.798B 0.00
Xeris Biopharma Holdings (XERS) United States $0.762B 0.00
Akebia Therapeutics (AKBA) United States $0.735B 0.00
AleAnna (ANNA) United States $0.667B 0.00
KalVista Pharmaceuticals (KALV) United States $0.600B 0.00
Xencor (XNCR) United States $0.574B 0.00
Bioventus (BVS) United States $0.569B 14.44
USANA Health Sciences (USNA) United States $0.560B 12.17
Elite Pharmaceuticals (ELTP) United States $0.552B 0.00
Regulus Therapeutics (RGLS) United States $0.545B 0.00
Savara (SVRA) United States $0.541B 0.00
Relay Therapeutics (RLAY) United States $0.502B 0.00
Zevra Therapeutics (ZVRA) United States $0.487B 0.00
CytoDyn (CYDY) United States $0.481B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.478B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.470B 0.00
Altimmune (ALT) United States $0.446B 0.00
Siga Technologies (SIGA) United States $0.433B 9.05
Tourmaline Bio (TRML) United States $0.427B 0.00
Organogenesis (ORGO) United States $0.410B 0.00
Verve Therapeutics (VERV) United States $0.390B 0.00
Oruka Therapeutics (ORKA) United States $0.386B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.352B 9.52
Heron Therapeutics (HRTX) United States $0.293B 0.00
Nature's Sunshine Products (NATR) United States $0.273B 25.22
Aquestive Therapeutics (AQST) United States $0.243B 0.00
ProKidney (PROK) United States $0.237B 0.00
MediWound (MDWD) Israel $0.222B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.195B 0.00
Wellgistics Health (WGRX) United States $0.193B 0.00
OmniAb (OABI) United States $0.189B 0.00
Nanobiotix S.A (NBTX) France $0.186B 0.00
Avita Medical (RCEL) United States $0.178B 0.00
4D Molecular Therapeutics (FDMT) United States $0.176B 0.00
Esperion Therapeutics (ESPR) United States $0.171B 0.00
Liminatus Pharma (LIMN) $0.164B 0.00
Journey Medical (DERM) United States $0.156B 0.00
Profound Medical (PROF) Canada $0.150B 0.00
Korro Bio (KRRO) United States $0.148B 0.00
Aldeyra Therapeutics (ALDX) United States $0.145B 0.00
Aclaris Therapeutics (ACRS) United States $0.141B 0.00
Inhibikase Therapeutics (IKT) United States $0.139B 0.00
Protara Therapeutics (TARA) United States $0.132B 0.00
Nektar Therapeutics (NKTR) United States $0.129B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.127B 0.00
Larimar Therapeutics (LRMR) United States $0.125B 0.00
Lyell Immunopharma (LYEL) United States $0.122B 0.00
Innate Pharma SA (IPHYF) France $0.122B 0.00
Achieve Life Sciences (ACHV) Canada $0.115B 0.00
VAXART, INC (VXRT) United States $0.114B 0.00
Lexeo Therapeutics (LXEO) United States $0.109B 0.00
Fractyl Health (GUTS) United States $0.104B 0.00
Cassava Sciences (SAVA) United States $0.100B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.099B 0.00
OptiNose (OPTN) United States $0.098B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.095B 0.00
Cardiol Therapeutics (CRDL) Canada $0.093B 0.00
Galectin Therapeutics (GALT) United States $0.084B 0.00
Dominari Holdings (DOMH) United States $0.082B 0.00
Champions Oncology (CSBR) United States $0.082B 13.45
Cumberland Pharmaceuticals (CPIX) United States $0.082B 60.56
Arch Biopartners (ACHFF) Canada $0.080B 0.00
Inotiv (NOTV) United States $0.077B 0.00
Pyxis Oncology (PYXS) United States $0.076B 0.00
Telomir Pharmaceuticals (TELO) United States $0.076B 0.00
ESSA Pharma (EPIX) Canada $0.075B 0.00
Unicycive Therapeutics (UNCY) United States $0.073B 0.00
Surrozen (SRZN) United States $0.069B 0.00
Assertio Holdings (ASRT) United States $0.068B 0.00
Metagenomi (MGX) United States $0.064B 0.00
Nutriband (NTRB) United States $0.064B 0.00
Vivani Medical (VANI) United States $0.063B 0.00
Context Therapeutics (CNTX) United States $0.063B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.060B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.059B 0.00
Gain Therapeutics (GANX) United States $0.058B 0.00
Prelude Therapeutics (PRLD) United States $0.052B 0.00
Mural Oncology (MURA) Ireland $0.048B 0.00
Century Therapeutics (IPSC) United States $0.048B 0.00
PMV Pharmaceuticals (PMVP) United States $0.045B 0.00
Karyopharm Therapeutics (KPTI) United States $0.044B 0.00
Avalo Therapeutics (AVTX) United States $0.043B 0.00
NRx Pharmaceuticals (NRXP) United States $0.042B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.042B 0.00
Iterum Therapeutics (ITRM) Ireland $0.040B 0.00
ElectroCore (ECOR) United States $0.039B 0.00
Acrivon Therapeutics (ACRV) United States $0.037B 0.00
Rafael Holdings (RFL) United States $0.034B 0.00
SCYNEXIS (SCYX) United States $0.032B 0.00
FibroGen (FGEN) United States $0.032B 0.00
PolyPid (PYPD) Israel $0.029B 0.00
Tempest Therapeutics (TPST) United States $0.025B 0.00
CASI Pharmaceuticals (CASI) China $0.023B 0.00
Enlivex Therapeutics (ENLV) Israel $0.023B 0.00
Natural Alternatives (NAII) United States $0.020B 0.00
DURECT (DRRX) United States $0.020B 0.00
BioVie (BIVI) United States $0.020B 0.00
Lipocine (LPCN) United States $0.019B 0.00
Jupiter Neurosciences (JUNS) United States $0.019B 0.00
VYNE Therapeutics (VYNE) United States $0.019B 0.00
Mannatech (MTEX) United States $0.017B 0.00
TherapeuticsMD (TXMD) United States $0.017B 0.00
Relmada Therapeutics (RLMD) United States $0.017B 0.00
GlycoMimetics (GLYC) United States $0.017B 0.00
Ernexa Therapeutics (ERNA) United States $0.014B 0.00
MEI Pharma (MEIP) United States $0.014B 0.00
Vivos Therapeutics (VVOS) United States $0.014B 0.00
ProPhase Labs (PRPH) United States $0.013B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.013B 0.00
Scienture Holdings (SCNX) United States $0.012B 0.00
Cosmos Health (COSM) United States $0.012B 0.00
BioLineRx (BLRX) Israel $0.011B 0.00
Talphera (TLPH) United States $0.010B 0.00
Minerva Neurosciences (NERV) United States $0.010B 1.77
Kiora Pharmaceuticals (KPRX) United States $0.010B 0.00
Biomerica (BMRA) United States $0.009B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Phio Pharmaceuticals (PHIO) United States $0.009B 0.00
Ainos (AIMD) United States $0.008B 0.00
Carisma Therapeutics (CARM) United States $0.008B 0.00
Mangoceuticals (MGRX) United States $0.008B 0.00
Citius Pharmaceuticals (CTXR) United States $0.008B 0.00
Klotho Neurosciences (KLTO) United States $0.008B 0.00
Traws Pharma (TRAW) United States $0.007B 0.00
Lyra Therapeutics (LYRA) United States $0.007B 0.00
Nuvilex (PMCB) United States $0.007B 0.00
Indaptus Therapeutics (INDP) United States $0.006B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.006B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.006B 0.00
Plus Therapeutics (PSTV) United States $0.006B 0.00
TransCode Therapeutics (RNAZ) United States $0.006B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
Aptorum Group (APM) United Kingdom $0.005B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.004B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
Alaunos Therapeutics (TCRT) United States $0.004B 0.00
Conduit Pharmaceuticals (CDT) United States $0.004B 0.00
Jaguar Animal Health (JAGX) United States $0.004B 0.00
PainReform (PRFX) Israel $0.004B 0.00
Incannex Healthcare (IXHL) Australia $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
Redhill Biopharma (RDHL) Israel $0.003B 0.00
InMed Pharmaceuticals (INM) Canada $0.003B 0.00
SciSparc (SPRC) Israel $0.003B 0.00
CERo Therapeutics Holdings (CERO) United States $0.003B 0.00
Heatwurx (PCSA) United States $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.001B 0.00
SHINECO (SISI) China $0.001B 0.00
China SXT Pharmaceuticals (SXTC) China $0.001B 0.00
Petros Pharmaceuticals (PTPI) United States $0.000B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
Aditxt (ADTX) United States $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00